PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00358345|
Recruitment Status : Completed
First Posted : July 31, 2006
Last Update Posted : January 15, 2008
The primary objective of this study is to assess the ability of the PreView PHP(study device)to detect newly diagnosed non-treated Choroidal Neovascularization (CNV)lesion associate with advanced Age-related Macular Degeneration (AMD) or Myopia and differentiate them from Intermediate AMD or Geographic Atrophy (GA)or patients with high Myopia with no CNV.
This study secondary is to enhance NotalVision normative database.
|Condition or disease|
|Age Related Macular Degeneration|
|Study Type :||Observational|
|Actual Enrollment :||347 participants|
|Official Title:||PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization|
|Study Start Date :||October 2003|
|Actual Study Completion Date :||September 2007|
Newly diagnosed CNV
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00358345
|Tel Aviv Sourasky medical center|
|Tel Aviv, Israel|
|Study Director:||Ofer Sharon, MD||Notal Vision|